Cormorant Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Cormorant Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,321	Closed	-$162K	–	80
2016 Q4	$162K	Hold	17,321	–	–	0.02%	74
2016 Q3	$169K	Hold	17,321	–	–	0.02%	81
2016 Q2	$245K	Buy	17,321 +211	+1%	+$3.29K	0.03%	79
2016 Q1	$239K	Hold	17,110	–	–	0.04%	80
2015 Q4	$349K	Hold	17,110	–	–	0.04%	79
2015 Q3	$225K	Hold	17,110	–	–	0.04%	86
2015 Q2	$262K	Sell	17,110 -8,900	-34%	-$171K	0.03%	79
2015 Q1	$520K	Sell	26,010 -34,590	-57%	-$773K	0.08%	66
2014 Q4	$1.27M	Hold	60,600	–	–	0.2%	59
2014 Q3	$1.13M	Sell	60,600 -158,000	-72%	-$2.86M	0.23%	58
2014 Q2	$5.05M	Buy	+218,600	New	+$3.85M	1.34%	28

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cormorant Asset Management's AGTC Position: Q1 2017 in Review

Cormorant Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 17,321 shares — an estimated $162K sold.

Cormorant Asset Management first reported a position in AGTC in Q2 2014 and held it in 11 quarters. The position peaked at $5.05M in Q2 2014. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

Cormorant Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
Cormorant Asset Management sold 17,321 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $162K.
Cormorant Asset Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 11 quarters.
Cormorant Asset Management's Applied Genetic Technologies Corporation position peaked at $5.05M in Q2 2014.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Cormorant Asset Management's 13F filing for Q1 2017, filed 15 May 2017.